[Vasopressin and oxytocin as neuromediators]

Vasopressin and oxytocin are peptide hormones which act on a variety of target organs, including kidney, smooth muscle, liver, and anterior pituitary. During the last decade, it has become apparent that these two neuropeptides may in addition act as neurotransmitters. We review a number of arguments which support this conjecture: 1) Vasopressin and oxytocin are not only synthesized in hypothalamoneurohypophysial neurones, but also in other--hypothalamic and extrahypothalamic--cell bodies whose axon projects to the limbic system, the brainstem and the spinal cord. 2) Vasopressin and oxytocin can be shed from central axons by the same secretory mechanism as are classical neurotransmitters. 3) Specific binding sites having a high affinity for vasopressin and/or oxytocin are present in the central nervous system. These binding sites represent functional receptors, because agonist binding leads to an increase in membrane phosphatidylinositol turnover. 4) Receptors, or at least part of them, are localized on neurones, since application of exogenous vasopressin and oxytocin alters the rate of firing of single neurones present in regions where binding sites have been detected autoradiographically. 5) Central vasopressin and oxytocin may play a role in brain functions, since in situ injection of antagonists interferes with physiological regulations.